Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE

Mostrar otras versiones (1)

Samarium-153 is a promising theranostic radionuclide, but low molar activities (Am) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of $^{152}$Sm in the SCK CEN BR2 reactor with mass separation at...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeulen, Koen, Van de Voorde, Michiel, Segers, Charlotte, Coolkens, Amelie, Pérez, Sunay Rodriguez, Daems, Noami, Duchemin, Charlotte, Crabbé, Melissa, Opsomer, Tomas, Vargas, Clarita Saldarriaga, Heinke, Reinhard, Lambert, Laura, Bernerd, Cyril, Burgoyne, Andrew R, Cocolios, Thomas Elias, Stora, Thierry, Ooms, Maarten
Lenguaje:eng
Publicado: 2022
Materias:
Health Physics and Radiation Effects
Acceso en línea:https://dx.doi.org/10.3390/pharmaceutics14122566
http://cds.cern.ch/record/2849042

Internet

https://dx.doi.org/10.3390/pharmaceutics14122566
http://cds.cern.ch/record/2849042

Ejemplares similares